Ublituximab-Xiiy: Benefits, Reviews, Info, Side Effects!
Ublituximab-Xiiy is a monoclonal antibody that has been approved by the FDA for the treatment of certain types of B-cell lymphomas and chronic lymphocytic leukemia. This medication works by targeting